iifl-logo

EPIC Enzymes Pharma & Industrial Chemicals Ltd Share Price Live

Add as a Preferred Source on Google
1,396.15
(81546.20%)
Aug 22, 2024|02:54:00 PM

EPIC Enzymes Pharma & Industrial Chemicals Ltd has been delisted from the stock exchange.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

EPIC Enzymes Pharma & Industrial Chemicals Ltd KEY RATIOS

Sector

Chemicals

Open

₹1,420

Prev. Close

₹1.71

Turnover(Lac.)

₹11.6

Day's High

₹1,420

Day's Low

₹1,394.7

52 Week's High

₹0

52 Week's Low

₹0

Book Value

₹-22.51

Face Value

₹10

Mkt Cap (₹ Cr.)

1,199.29

P/E

0

EPS

0

Divi. Yield

0

EPIC Enzymes Pharma & Industrial Chemicals Ltd Corporate Action

No Record Found

EPIC Enzymes Pharma & Industrial Chemicals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

EPIC Enzymes Pharma & Industrial Chemicals Ltd SHAREHOLDING SNAPSHOT

10 May, 2026|05:16 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 27.22%

Foreign: 0.00%

Indian: 27.22%

Non-Promoter- 72.77%

Institutions: 0.00%

Non-Institutions: 72.77%

Custodian: 0.00%

Share PriceShare Price

EPIC Enzymes Pharma & Industrial Chemicals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2012Mar-2011Mar-2010Mar-2009

Equity Capital

8.57

8.57

8.57

8.57

Preference Capital

0

0

0

0

Reserves

-27.61

-27.38

-14.06

-12.99

Net Worth

-19.04

-18.81

-5.49

-4.42

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2012Mar-2011

Revenue

0

0.22

yoy growth (%)

-100

Raw materials

0

-0.99

As % of sales

0

447.9

Employee costs

-0.02

-0.07

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2012Mar-2011

Profit before tax

-0.22

-3.61

Depreciation

-0.05

-0.05

Tax paid

0

0

Working capital

-0.26

Other operating items

View Cash Flow
Y/e 31 MarMar-2012Mar-2011

Growth matrix (%)

Revenue growth

-100

Op profit growth

-82.56

EBIT growth

-124.15

Net profit growth

-98.37

View Ratios

No Record Found

EPIC Enzymes Pharma & Industrial Chemicals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Pidilite Industries Ltd

PIDILITIND

1,476.15

64.131,47,699.56547.390.693,284.892.77

SRF Ltd

SRF

2,780.75

45.8682,166507.0603,498.93427.74

Linde India Ltd

LINDEINDIA

7,806.3

114.7666,968.25191.590.15701.03463.31

Gujarat Fluorochemicals Ltd

FLUOROCHEM

3,773.65

60.7741,712.791270.081,026620.02

Godrej Industries Ltd

GODREJIND

1,216.2

041,341.11-21.0501,226.9752.7

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT EPIC Enzymes Pharma & Industrial Chemicals Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

P K Mahajan

Additional Director

Subhash Kumar

Additional Director

Indresh Bala

Registered Office

514 Persepolis,

Sector 17 Vashi,

Maharashtra - 400703

Tel: 91-22-27890922/2239

Website: -

Email: epicsales@vsnl.net

Registrar Office

C-13 Pannalal Silk,

Mills Cmpd LBS Marg, Bhandup West,

Mumbai - 400 078

Tel: 91-022-25963838

Website: www.linkintime.co.in

Email: rnt.helpdesk@linkintime.co.in/mumbai@linkintime.co.in

Summary

Incorporated in Nov.82 as a private limited company, Enzymes Pharmaceuticals & Industrial Chemicals (EPIC) was converted into a public limited company in Nov.92. The promoters were Ratanshaw Elavia an...
Read More

Reports by EPIC Enzymes Pharma & Industrial Chemicals Ltd

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.